fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search

COVID-19 Booster Shot Increases Protection Against Delta Variant Infection by 85%, Study Indicates

COVID-19 booster shot
A Sheba study suggests that higher levels of antibodies following a third dose of the Pfizer-BioNTech vaccine correlate with a reduced risk of COVID-19 infection.

According to a new Sheba Medical Center and Tel Aviv University study, published in the scientific journal Nature Immunology, the effectiveness of a third COVID-19 vaccine dose against PCR-confirmed infection, regardless of symptoms, is 85.6% higher compared to two doses.

In order to analyze the effectiveness of the third vaccine dose, researchers administered the jab to 12,290 healthcare workers who were not previously infected with COVID-19 and had already received the first and second vaccine doses.
Results indicate that out of the the12,290 participants, 407 (3.3%) tested positive for COVID-19 on a PCR test.

Data gathered as part of the study demonstrated that while the increase in antibodies is relatively small at around 170%, a 600% increase in neutralizing antibodies, which bind pathogens and prevent them from spreading infection, was recorded in comparison to the second vaccine dose.

The study also found that the higher levels of antibodies following a third dose of the Pfizer-BioNTech vaccine correlate with a reduced risk of COVID-19 infection.

Related
Doctor analyzing hemophilia blood with a microscope. The focus of the shot is on the blood.
Breakthrough Hemophilia Treatment by Prof. Gili Kenet Empowers Boy's Dream
Prof. Gili Kenet, a renowned pediatric hematologist at Sheba’s National Hemophilia Center and an esteemed professor at the Sackler School of Medicine, unveiled a groundbreaking…
Read More
Text "SCIENCE DOSE" with a magnifying glass next to it zooming in on cells and viruses. Additional elements include a syringe, microscope, and blood cells.
Navigating Retinoblastoma: Expert Analysis by Prof. Didi Fabian
Prof. Didi Fabian, a senior ocular oncologist at Sheba’s Goldschleger Eye Institute and Director of Sheba Global Ophthalmology, recently delved into retinoblastoma, an eye cancer…
Read More
A pregnant woman smiling while talking to obstetricians and gynecologists at a maternity center.
Navigating IVF Treatment at Sheba: Hailey's Journey to Motherhood
Navigating complex and uncertain emotions is a common experience for individuals undergoing IVF treatment. Hailey, a determined woman with a desire to embrace motherhood, embarked…
Read More